← FDA DRUG APPROVALS

FDA ANDA · ANDA089415

PROCAINAMIDE HYDROCHLORIDE

Sponsor: ABRAXIS PHARM

APPLICATION
ANDA089415
TYPE
ANDA
ORIGINAL APPROVAL
1986-11-17
LATEST ACTION
1991-12-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINAMIDE HYDROCHLORIDEDiscontinued
PROCAINAMIDE HYDROCHLORIDE 100MG/ML · INJECTABLE · INJECTION

Approval history

1991-12-30Labeling · Supplement 7AP
1988-10-28Labeling · Supplement 1AP
1986-11-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →